Exact Sciences Corporation (EXAS) Financial Statements (2023 and earlier)

Company Profile

Business Address 5505 ENDEAVOR LANE
MADISON, WI 53719
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:632,0571,030,7731,840,293323,9291,124,182424,715
Cash and cash equivalents242,493315,4711,491,288 160,43077,491
Short-term investments394,713718,341350,2201,716963,752347,224
Other undisclosed cash, cash equivalents, and short-term investments (5,149)(3,039)(1,215)322,213  
Receivables158,043216,645233,185130,66744,23926,419
Inventory, net of allowances, customer advances and progress billings118,259104,99492,26561,72439,14826,027
Inventory118,259104,99492,26561,72439,14826,027
Other undisclosed current assets73,89873,82532,85140,63920,49810,055
Total current assets:982,2571,426,2372,198,594556,9591,228,067487,216
Noncurrent Assets
Operating lease, right-of-use asset167,003174,225125,947126,444
Property, plant and equipment 684,756580,248450,683455,325245,25979,986
Intangible assets, net (including goodwill), including:4,302,2804,429,5832,086,0982,346,74746,28122,160
Goodwill2,346,0402,335,1721,237,6721,203,19717,279 
Intangible assets, net (excluding goodwill)1,956,2402,094,411848,4261,143,55028,95122,160
Other undisclosed intangible assets, net (including goodwill)     51 
Other noncurrent assets90,57774,59163,77020,2934,4159,198
Other undisclosed noncurrent assets      
Total noncurrent assets:5,244,6165,258,6472,726,4982,948,809295,955111,344
TOTAL ASSETS:6,226,8736,684,8844,925,0923,505,7681,524,022598,560
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities374,132466,385269,313219,302128,78565,261
Accounts payable74,91667,82935,70925,97328,14116,135
Accrued liabilities299,216398,556233,604193,329100,64449,126
Deferred revenue 3,1001,000  
Debt3,2006,200256,7838,7258182
Contract with customer, liability500
Other liabilities10,24930,97338,2658,4673,2042,681
Other undisclosed current liabilities22,06612,51011,483 4,093 
Total current liabilities:412,747517,068575,844236,494136,59068,124
Noncurrent Liabilities
Long-term debt and lease obligation2,236,1062,362,3981,464,177142,69724,0734,269
Long-term debt, excluding current maturities2,236,1062,180,2321,343,10224,03224,0734,269
Liabilities, other than long-term debt534,858417,78261,58234,9119,4755,633
Other liabilities352,459417,78261,58234,9119,4755,633
Operating lease, liability182,399182,166121,075118,665
Other undisclosed noncurrent liabilities    803,605672,943116
Total noncurrent liabilities:2,770,9642,780,1801,525,759981,213706,49110,018
Total liabilities:3,183,7113,297,2482,101,6031,217,707843,08178,142
Equity
Equity, attributable to parent3,043,1623,387,6362,823,4892,288,061680,941520,418
Common stock1,7801,7381,5951,4771,2321,205
Additional paid in capital6,311,6446,028,8614,789,6573,406,4401,716,8941,380,577
Accumulated other comprehensive income (loss)(5,236)(1,443)526(100)(1,422)(750)
Accumulated deficit(3,265,026)(2,641,520)(1,968,289)(1,119,756)(1,035,763)(860,614)
Total equity:3,043,1623,387,6362,823,4892,288,061680,941520,418
TOTAL LIABILITIES AND EQUITY:6,226,8736,684,8844,925,0923,505,7681,524,022598,560

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues2,084,2791,767,0871,491,391876,293454,462265,989
Revenue, net265,989
Cost of revenue(574,394)(458,757)(354,324)(216,717)(117,982)(79,196)
Gross profit:1,509,8851,308,3301,137,067659,576336,480186,793
Operating expenses(2,090,152)(2,143,798)(1,928,751)(893,358)(495,951)(305,103)
Other operating expense, net(13,244)     
Other undisclosed operating income (loss)  (20,210)23,665   
Operating loss:(593,511)(855,678)(768,019)(233,782)(159,471)(118,310)
Nonoperating income (expense)(39,059)13,172(89,086)(35,069)(15,586)3,726
Investment income, nonoperating  31,7786,89726,53021,2033,932
Interest and debt expense(19,634)(18,606)(95,983)(61,599)(2,273)(54)
Loss from continuing operations before equity method investments, income taxes:(652,204)(861,112)(953,088)(330,450)(177,330)(114,638)
Other undisclosed income from continuing operations before income taxes19,63418,60695,98361,5992,27354
Loss from continuing operations before income taxes:(632,570)(842,506)(857,105)(268,851)(175,057)(114,584)
Income tax expense (benefit)9,064246,8818,572184,858(92)187
Loss from continuing operations:(623,506)(595,625)(848,533)(83,993)(175,149)(114,397)
Loss before gain (loss) on sale of properties:(595,625)(848,533)(83,993)(175,149)(114,397)
Net loss available to common stockholders, diluted:(623,506)(595,625)(848,533)(83,993)(175,149)(114,397)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(623,506)(595,625)(848,533)(83,993)(175,149)(114,397)
Other comprehensive income (loss)  (2,162)7711,322(708) 
Comprehensive loss:(623,506)(597,787)(847,762)(82,671)(175,857)(114,397)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3,793)193(145) 36(332)
Comprehensive loss, net of tax, attributable to parent:(627,299)(597,594)(847,907)(82,671)(175,821)(114,729)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: